XML 32 R8.htm IDEA: XBRL DOCUMENT v3.25.0.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Cash flows from operating activities:      
Net loss $ (31,315) $ (46,366) $ (68,495)
Depreciation, Depletion and Amortization 5,064 4,717 2,707
Stock-based compensation expenses 26,264 29,980 23,645
Amortization of deferred contract acquisition and fulfillment costs 11,447 11,669 10,865
Non-cash interest income, net (1,219) (1,023) (146)
Loss on sale of property and equipment 0 0 185
Losses (Gain) on foreign exchange (90) (728) 1,424
Decrease (Increase) in trade receivables 3,334 5,475 (11,277)
Decrease (Increase) in prepaid expenses and other current assets and other assets, noncurrent (949) 648 429
Increase in deferred contract acquisition and fulfillment costs (7,497) (6,561) (11,558)
Increase (Decrease) in trade payables (534) (5,884) 3,132
Increase (decrease) in accrued expenses and other current liabilities 5,376 797 (1,937)
Increase (Decrease) in employees and payroll accruals 2,748 (2,233) (3,743)
Increase (Decrease) in other liabilities, noncurrent (14) 443 (51)
Increase in deferred revenue 458 1,626 7,465
Operating lease right-of-use assets and lease liabilities, net (840) (863) 527
Net cash provided by (used in) operating activities 12,233 (8,303) (46,828)
Cash flows from investing activities:      
Investment in available-for-sale marketable securities (50,874) (47,708) (60,165)
Proceeds from maturities of available-for-sale marketable securities 38,981 51,976 18,985
Purchases of property and equipment (521) (2,607) (1,218)
Capitalized internal-use software development costs 0 (1,493) (4,759)
Investment in restricted bank deposit 0 (1,751) (2,600)
Net cash used in investing activities (12,414) (1,583) (49,757)
Cash flows from financing activities:      
Proceeds from long-term loans 0 3,500 0
Repayment of long-term loans (2,187) (4,500) (3,000)
Principal payments on finance leases 0 0 (136)
Proceeds from exercise of stock options 1,620 1,383 2,732
Payment of debt issuance costs (17) (274) (125)
Payments for Repurchase of Common Stock (2,920) 0 0
Payments on account of repurchase of common stock (30) 0 0
Net Cash Provided by (Used in) Financing Activities (3,534) 109 (529)
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations 90 728 (1,424)
Net decrease in cash, cash equivalents and restricted cash (3,625) (9,049) (98,538)
Cash, cash equivalents and restricted cash at the beginning of the year 36,784 45,833 144,371
Cash, cash equivalents and restricted cash at the end of the year 33,159 36,784 45,833
Supplemental disclosure of non-cash activity:      
Purchase of property, equipment, internal-use software, and intangible asset in credit 213 43 355
Lease liabilities arising from right-of-use assets 0 0 23,712
Capitalized stock-based compensation cost 645 845 296
Pending proceeds from option exercises 217 79 227
Lease incentive recognized as leasehold improvements 0 4,924 1,711
Supplemental disclosure of cash flow information      
Cash paid for income taxes, net 3,774 4,294 8,873
Cash paid for interest 2,692 2,953 2,301
Reconciliation of cash, cash equivalents, and restricted cash to the consolidated balance sheet      
Cash and cash equivalents 33,059 36,684 44,625
Restricted cash included in other assets, noncurrent 100 100 1,208
Total cash, cash equivalents, and restricted cash $ 33,159 $ 36,784 $ 45,833